Between a rock and a hard place: anticoagulation management for ECMO
Medizinische Klinik - Intensivmedizin und Notfallmedizin · 2024
DOI: 10.1007/s00063-024-01116-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2024. Verfasst von Nina Buchtele und 1 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit 13i2, Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. nina.buchtele@meduni…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Anticoagulants, Hemorrhage, Heparin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.
Abstract (Originalsprache)
Anticoagulation is an essential component of optimal extracorporeal membrane oxygenation (ECMO) management. Unfractionated heparin is still the anticoagulant of choice in most centers due to longstanding familiarity with the agent. Disadvantages include alterations in drug responses due to its capability to bind multiple heparin-binding proteins that compete with antithrombin and the potential for heparin-induced thrombocytopenia. In such cases, direct thrombin inhibitors are the treatment of choice but pose difficulties in monitoring due to the limited experience and target ranges for non-aPTT-guided management (aPTT: activated partial thromboplastin time). The current trend toward low-dose anticoagulation, especially for venovenous ECMO, is supported by data associating bleeding complications with mortality but not thromboembolic events, which include circuit thrombosis. However, only prospective data will provide appropriate answers to how to individualize anticoagulation, transfusions, and bleeding management which is currently only supported by expert opinion. Empiric therapy for ECMO patients based on laboratory coagulation alone should always be critically questioned. In summary, only collaboration and future studies of coagulation management during ECMO will help us to make this life-saving therapy that has become part of daily life of the intensivist even safer and more effective. Until then, a fundamental understanding of coagulation and bleeding management, as well as pearls and pitfalls of monitoring, is essential to optimize anticoagulation during ECMO. This article is freely available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Intensive Care Unit 13i2, Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. nina.buchtele@meduniwien.ac.at.
- Department of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University School of Medicine, Durham, NC, USA.
Förderung
- Medical University of Vienna
Zitieren
APA
Buchtele, N., & Levy, J. H. (2024). Between a rock and a hard place: anticoagulation management for ECMO. Medizinische Klinik - Intensivmedizin und Notfallmedizin. https://doi.org/10.1007/s00063-024-01116-0
Vancouver
Buchtele N, Levy JH. Between a rock and a hard place: anticoagulation management for ECMO. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2024. doi:10.1007/s00063-024-01116-0
BibTeX
@article{Buchtele2024,
author = {Buchtele, Nina and Levy, Jerrold H},
title = {Between a rock and a hard place: anticoagulation management for ECMO},
journal = {Medizinische Klinik - Intensivmedizin und Notfallmedizin},
year = {2024},
doi = {10.1007/s00063-024-01116-0}
}
EUVIMED